COMMITMENTS AND CONTINGENCIES (Tables)

6 Months Ended

Jun. 30, 2017

Commitments and Contingencies Disclosure [Abstract]

Schedule of Contingent Consideration

A reconciliation of the opening balances to the closing balances of these Level 3 measurements is as follows (in thousands):

	Contingent Considerations Liabilities Related to Acquisition of Derma Sciences (See Note 2)					Contingent Consideration Liability Related to Acquisition of Confluent Surgical, Inc.					Location in Financial Statements
	Short-term			Long-term		Short-term		Long-term
Balance as of January 1, 2017	$	—		$	—	$	—	$	22,036
Additions from acquisition of Derma Sciences	33,707			3,467		—		—
Transfers from long-term to current portion	—			—		4,662		(4,662		)
Payments	(26,598		)	—		—		—
(Gain) loss from change in fair value of contingent consideration liabilities	(2,359		)	82		—		148			Selling, general and administrative
Balance as of June 30, 2017	$	4,750		$	3,549	$	4,662	$	17,522

A reconciliation of the opening balances to the closing balances of these Level 3 measurements is as follows (in thousands):

	Supply Agreement Liability - Short-term			Above Market Supply Agreement Liability - Short-term		Above Market Supply Agreement Liability - Long-term			Location in Financial Statements
Balance as of January 1, 2017	$	166		$	—	$	2,648
Payments	(166		)			(273		)
Transfer from long-term to current portion	—			2,101		(2,101		)
Loss from increase in fair value	—			274		579			Selling, general and administrative
Balance as of June 30, 2017	$	—		$	2,375	$	853